This video presents a detailed pathological analysis of a rare soft tissue tumor, diagnosed in a 30-year-old man with a slow-growing thigh mass. The presentation focuses on the key diagnostic features of a "superficial CD34-positive fibroblastic tumor." Morphologically, the tumor is characterized by a paradoxical combination of dramatic, bizarre pleomorphism but a strikingly low mitotic rate, a crucial clue distinguishing it from high-grade sarcomas like undifferentiated pleomorphic sarcoma (UPS). Key immunohistochemical findings include diffuse, strong CD34 positivity and focal keratin expression. The speaker explains that this entity has a low metastatic potential and a significantly better prognosis than its mimics, underscoring the importance of accurate diagnosis to avoid overtreatment. The lecture also touches upon the challenges of tumor nomenclature and the value of pathologists providing clear, actionable comments in their reports to guide clinicians.
Diagnosing a Rare Pleomorphic Tumor: A Case Study
0:53 Case Presentation: The case involves a highly cellular tumor in the deep dermis and subcutis of a 30-year-old man, composed of spindle cells with dramatic, bizarre atypia (pleomorphism).
2:28 The Key Diagnostic Clue: The speaker highlights a critical paradox: despite the extreme pleomorphism resembling a high-grade sarcoma, the tumor has a very low mitotic rate (less than 1 mitosis per 50-100 high-power fields). This discordance is a major clue to avoid a misdiagnosis of sarcoma.
3:30 Differential Diagnosis: This lesion must be distinguished from more aggressive tumors. It is unlikely to be undifferentiated pleomorphic sarcoma (UPS) or myxofibrosarcoma due to the low mitotic rate and patient's young age. It is also distinct from atypical fibroxanthoma, which typically occurs in sun-damaged skin of the elderly.
5:02 Additional Morphological Clues: Other features supporting the diagnosis include nuclear pseudo-inclusions, foamy (xanthomatous) cells, and hemosiderin pigment within the tumor.
5:58 Immunohistochemistry Profile: The diagnosis is confirmed with immunohistochemistry, which shows the tumor cells are diffusely and strongly positive for CD34 and focally positive for pan-cytokeratin.
7:31 Final Diagnosis: The tumor is identified as a superficial CD34-positive fibroblastic tumor, a rare entity. The speaker notes that while this is the official name, it fails to capture the clinically important feature of dramatic pleomorphism.
8:05 Favorable Prognosis: This tumor has low metastatic potential and is considered an "indeterminate" or low-grade malignancy. While recurrence is possible without complete excision, its behavior is far better than that of a high-grade sarcoma.
12:41 The Role of the Pathologist: The speaker concludes by emphasizing the importance of pathologists providing clear, educational comments in their reports to explain the diagnosis, its clinical implications, and recommended management, thereby helping clinicians and improving patient care.